NEWARK, Del.--(BUSINESS WIRE)--Strategic Diagnostics Inc. (Nasdaq:SDIX) - today announced that revenues for the second quarter of 2007 increased 19.2% to $6.7 million, compared to $5.6 million for the same period in 2006. Year-to-date revenues increased 12.3% to $13.4 million versus $11.9 million for the same period in 2006. Revenues for the second quarter were positively impacted by a 42% increase in sales of antibody products and services. In addition, sales of the Company’s RapidChek® line of food pathogen testing products grew 38% in the second quarter of 2007 as compared to the same period in 2006. Overall growth in the Company’s food safety division was negatively impacted by a 32% decrease in sales of Agricultural and GMO testing products. Overall, food safety division revenues grew 2% for the second quarter of 2007 as compared to the same period in 2006.
